West Pharmaceutical Services (WST) Short Interest Ratio & Short Volume $314.49 -23.63 (-6.99%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends West Pharmaceutical Services Short Interest DataWest Pharmaceutical Services (WST) has a short interest of 1.43 million shares, representing 1.99% of the float (the number of shares available for trading by the public). This marks a -7.14% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 777,534 shares to cover all short positions.Current Short Interest1,430,000 sharesPrevious Short Interest1,540,000 sharesChange Vs. Previous Month-7.14%Dollar Volume Sold Short$440.30 millionShort Interest Ratio2.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares72,420,000 sharesFloat Size72,000,000 sharesShort Percent of Float1.99%Today's Trading Volume1,087,580 sharesAverage Trading Volume777,534 sharesToday's Volume Vs. Average140% Short Selling West Pharmaceutical Services? Sign up to receive the latest short interest report for West Pharmaceutical Services and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWST Short Interest Over TimeWST Days to Cover Over TimeWST Percentage of Float Shorted Over Time Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover West Pharmaceutical Services Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,430,000 shares $440.30 million -7.1%2.0%2.6 $307.90 10/15/20241,540,000 shares $448.05 million +6.9%2.1%2.6 $290.94 9/30/20241,440,000 shares $432.23 million -7.7%2.0%2.6 $300.16 9/15/20241,560,000 shares $469.05 million +2.0%2.2%2.8 $300.67 8/31/20241,530,000 shares $479.85 million +21.4%2.1%2.5 $313.63 8/15/20241,260,000 shares $368.68 million +6.8%1.8%2 $292.60 Get the Latest News and Ratings for WST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,180,000 shares $361.28 million -4.8%1.6%1.8 $306.17 7/15/20241,240,000 shares $396.97 million +0.8%1.7%2.2 $320.14 6/30/20241,230,000 shares $405.15 million +0.8%1.7%2.3 $329.39 6/15/20241,220,000 shares $406.57 million -4.7%1.7%2.4 $333.25 5/31/20241,280,000 shares $424.20 million +12.3%1.8%2.6 $331.41 5/15/20241,140,000 shares $400.66 million +9.6%1.6%2.4 $351.46 4/30/20241,040,000 shares $371.70 million +6.6%1.4%2 $357.40 4/15/2024975,900 shares $369.68 million -13.6%1.3%1.8 $378.81 3/31/20241,130,000 shares $447.15 million -6.6%1.6%2.1 $395.71 3/15/20241,210,000 shares $469.02 million +0.8%1.7%2.3 $387.62 2/29/20241,200,000 shares $430.03 million +17.7%1.7%2.3 $358.36 2/15/20241,020,000 shares $357.71 million -12.1%1.4%2 $350.70 1/31/20241,160,000 shares $432.71 million +8.4%1.6%2.6 $373.03 1/15/20241,070,000 shares $371.04 million -8.6%1.5%2.5 $346.77 12/31/20231,170,000 shares $411.98 million -1.7%1.6%2.7 $352.12 12/15/20231,190,000 shares $426.26 million No Change1.6%2.9 $358.20 11/30/20231,190,000 shares $417.33 million -7.0%1.6%3.1 $350.70 11/15/20231,280,000 shares $442.85 million +35.9%1.7%3.5 $345.98 10/31/2023942,000 shares $299.83 million -13.6%1.3%2.7 $318.29 10/15/20231,090,000 shares $419.72 million +27.1%1.5%3.2 $385.06 9/30/2023857,300 shares $321.67 million -3.2%1.2%2.6 $375.21 9/15/2023885,200 shares $348.93 million -3.5%1.2%2.6 $394.18 8/31/2023916,900 shares $373.09 million +7.8%1.3%2.6 $406.90 8/15/2023850,900 shares $342.17 million +37.9%1.2%2.2 $402.13 7/31/2023617,100 shares $227.12 million -15.7%0.8%1.6 $368.04 7/15/2023731,700 shares $281.80 million -14.8%1.0%1.9 $385.13 6/30/2023858,300 shares $328.27 million -13.6%1.2%2.1 $382.47 6/15/2023993,500 shares $357.46 million +15.8%1.4%2.4 $359.80 5/31/2023858,300 shares $287.21 million -0.6%1.2%2 $334.63 5/15/2023863,800 shares $306.80 million -27.4%1.2%1.9 $355.18 4/30/20231,190,000 shares $429.88 million -11.9%1.6%2.2 $361.24 4/15/20231,350,000 shares $491.31 million +0.8%1.8%2.5 $363.93 3/31/20231,340,000 shares $464.27 million -14.7%1.8%2.3 $346.47 3/15/20231,570,000 shares $511.18 million +2.0%2.1%2.7 $325.59“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! 2/28/20231,540,000 shares $488.23 million -7.8%2.1%2.5 $317.03 2/15/20231,670,000 shares $466.23 million +24.6%2.3%2.7 $279.18 1/31/20231,340,000 shares $355.90 million +5.5%1.8%2.1 $265.60 1/15/20231,270,000 shares $318.39 million -7.3%1.7%1.7 $250.70 12/30/20221,370,000 shares $322.43 million +18.1%1.9%1.8 $235.35 12/15/20221,160,000 shares $275.01 million -19.4%1.6%1.5 $237.08 11/30/20221,440,000 shares $337.91 million +44.9%2.0%2 $234.66 11/15/2022993,800 shares $246.15 million +18.1%1.4%1.5 $247.69 10/31/2022841,400 shares $193.61 million +1.7%1.1%1.5 $230.10 10/15/2022827,400 shares $204.81 million -11.5%1.1%1.8 $247.53 9/30/2022934,600 shares $229.99 million +12.0%1.3%2.3 $246.08 9/15/2022834,700 shares $228.48 million +17.2%1.1%2.1 $273.73 8/31/2022712,200 shares $211.30 million -17.2%1.0%1.8 $296.69 8/15/2022860,500 shares $293.28 million -5.7%1.2%2.1 $340.82 7/31/2022912,100 shares $313.36 million -5.1%1.2%2.1 $343.56 7/15/2022960,800 shares $288.66 million +6.0%1.3%2.1 $300.44 6/30/2022906,800 shares $274.19 million +19.2%1.2%2 $302.37 6/15/2022761,000 shares $220.61 million +4.5%1.0%1.7 $289.89 5/31/2022728,100 shares $225.99 million -14.4%1.0%1.7 $310.38 5/15/2022850,700 shares $259.44 million -13.5%1.2%2 $304.97 4/30/2022983,400 shares $309.83 million -14.5%1.3%2.3 $315.06 4/15/20221,150,000 shares $438.40 million -4.2%1.6%2.7 $381.22 3/31/20221,200,000 shares $492.85 million -3.2%1.6%2.8 $410.71 3/15/20221,240,000 shares $477.93 million +20.4%1.7%2.9 $385.43 2/28/20221,030,000 shares $398.69 million No Change1.4%2.4 $387.08 2/15/20221,030,000 shares $396.93 million -13.5%1.4%2.4 $385.37 1/31/20221,190,000 shares $467.93 million +64.5%1.6%2.9 $393.22 1/15/2022723,600 shares $274.81 million -19.2%1.0%1.7 $379.78 12/31/2021895,900 shares $420.19 million -16.3%1.2%2.4 $469.01 12/15/20211,070,000 shares $474.57 million -4.5%1.5%2.8 $443.52 11/30/20211,120,000 shares $495.78 million -9.7%1.5%3 $442.66 11/15/20211,240,000 shares $523.85 million +36.1%1.7%3.5 $422.46 10/29/2021911,300 shares $391.75 million -7.9%1.2%2.6 $429.88 10/15/2021989,500 shares $400.56 million +13.1%1.4%3 $404.81 9/30/2021874,800 shares $371.39 million +11.1%1.2%2.7 $424.54 9/15/2021787,300 shares $356.25 million -13.8%1.1%2.4 $452.49 8/31/2021913,500 shares $412.55 million -13.8%1.2%2.8 $451.62 8/13/20211,060,000 shares $460.34 million +8.9%1.4%3.1 $434.28 7/30/2021973,000 shares $400.61 million +0.6%1.3%2.6 $411.73 7/15/2021967,000 shares $359.69 million -13.7%1.3%2.6 $371.96 6/30/20211,120,000 shares $402.19 million -0.9%1.5%2.9 $359.10 6/15/20211,130,000 shares $389.67 million +11.9%1.5%2.9 $344.84 5/28/20211,010,000 shares $350.99 million -1.0%1.4%2.5 $347.51 5/14/20211,020,000 shares $334.87 million +18.2%1.4%2.5 $328.30 4/30/2021862,900 shares $280.05 million +28.4%1.2%2 $324.55 4/15/2021672,300 shares $201.73 million -2.9%0.9%1.5 $300.06 3/31/2021692,500 shares $192.75 million +7.6%0.9%1.5 $278.34 3/15/2021643,800 shares $176.48 million +6.9%0.9%1.3 $274.12 2/26/2021602,000 shares $167.16 million -9.9%0.8%1.2 $277.68 2/12/2021668,400 shares $194.56 million -21.0%0.9%1.4 $291.09“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! 1/29/2021845,500 shares $252.74 million +20.9%1.2%1.8 $298.92 1/15/2021699,100 shares $208.84 million +6.2%1.0%1.6 $298.72 12/31/2020658,400 shares $184.31 million +11.6%0.9%1.6 $279.94 12/15/2020590,000 shares $156.30 million +7.6%0.8%1.4 $264.92 11/30/2020548,600 shares $152.49 million -8.3%0.8%1.2 $277.96 10/30/2020626,900 shares $172.54 million -17.3%0.9%1.4 $275.23 10/15/2020758,000 shares $218.42 million +10.9%1.0%1.6 $288.15 9/30/2020683,600 shares $187.92 million -3.6%0.9%1.3 $274.90 9/15/2020709,100 shares $201.65 million -4.6%1.0%1.3 $284.38 8/31/2020743,600 shares $211.15 million +0.9%1.0%1.3 $283.96 8/14/2020736,700 shares $200.73 million +5.5%1.0%1.2 $272.47 7/31/2020698,100 shares $187.70 million -9.2%1.0%0.8 $268.87 7/15/2020768,700 shares $179.32 million -16.0%1.1%0.9 $233.28 6/30/2020915,500 shares $207.97 million +0.2%1.3%1.1 $227.17 6/15/2020914,100 shares $191.39 million +30.3%1.3%1.1 $209.37 5/29/2020701,500 shares $151.55 million -3.4%1.0%0.8 $216.04 5/15/2020725,900 shares $152.69 million -8.2%1.0%0.9 $210.35 4/30/2020791,000 shares $149.97 million +2.3%1.1%1.5 $189.60 4/15/2020773,400 shares $127.62 million -2.0%1.1%1.5 $165.01 3/31/2020789,400 shares $120.19 million -27.3%1.1%1.5 $152.25 3/13/20201,086,300 shares $176.99 million +8.6%1.5%2.7 $162.93 2/28/20201,000,000 shares $128.96 million -2.0%1.4%2.5 $128.96 2/14/20201,020,000 shares $146.41 million -1.0%1.4%2.3 $143.54 1/31/20201,030,000 shares $163.05 million +1.0%1.4%2.4 $158.30 1/15/20201,020,000 shares $165.44 million -23.9%1.4%2.3 $162.20 12/31/20191,340,000 shares $208.71 million +25.2%1.8%3.2 $155.75 WST Short Interest - Frequently Asked Questions What is West Pharmaceutical Services' current short interest? Short interest is the volume of West Pharmaceutical Services shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,430,000 shares of WST short. 1.99% of West Pharmaceutical Services' shares are currently sold short. Learn More on West Pharmaceutical Services' current short interest. What is a good short interest ratio for West Pharmaceutical Services? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WST shares currently have a short interest ratio of 3.0. Learn More on West Pharmaceutical Services's short interest ratio. Which institutional investors are shorting West Pharmaceutical Services? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of West Pharmaceutical Services: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Garda Capital Partners LP, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, Wealth Enhancement Advisory Services LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for West Pharmaceutical Services? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.99% of West Pharmaceutical Services' floating shares are currently sold short. Is West Pharmaceutical Services' short interest increasing or decreasing? West Pharmaceutical Services saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 1,430,000 shares, a drop of 7.1% from the previous total of 1,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is West Pharmaceutical Services' float size? West Pharmaceutical Services currently has issued a total of 72,420,000 shares. Some of West Pharmaceutical Services' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. West Pharmaceutical Services currently has a public float of 72,000,000 shares. How does West Pharmaceutical Services' short interest compare to its competitors? 1.99% of West Pharmaceutical Services' shares are currently sold short. Here is how the short interest of companies compare to West Pharmaceutical Services: The Cooper Companies, Inc. (1.12%), Align Technology, Inc. (4.17%), Merit Medical Systems, Inc. (4.62%), Haemonetics Co. (10.39%), ICU Medical, Inc. (2.90%), DENTSPLY SIRONA Inc. (6.98%), Neogen Co. (9.08%), QuidelOrtho Co. (6.17%), STAAR Surgical (5.93%), Cerus Co. (4.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short West Pharmaceutical Services stock? Short selling WST is an investing strategy that aims to generate trading profit from West Pharmaceutical Services as its price is falling. WST shares are trading down $23.63 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against West Pharmaceutical Services? A short squeeze for West Pharmaceutical Services occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WST, which in turn drives the price of the stock up even further. How often is West Pharmaceutical Services' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WST, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies COO Short Interest ALGN Short Interest MMSI Short Interest HAE Short Interest ICUI Short Interest XRAY Short Interest NEOG Short Interest QDEL Short Interest STAA Short Interest CERS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:WST) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share West Pharmaceutical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.